Stephen J. Gold
Affiliations: | Molecular Psychiatry | University of Texas Southwestern Medical Center, Dallas, TX, United States |
Google:
"Stephen Gold"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Waugh JL, Celver J, Sharma M, et al. (2011) Association between regulator of G protein signaling 9-2 and body weight. Plos One. 6: e27984 |
| Psifogeorgou K, Psigfogeorgou K, Terzi D, et al. (2011) A unique role of RGS9-2 in the striatum as a positive or negative regulator of opiate analgesia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 5617-24 |
| Chen FS, Shim H, Morhardt D, et al. (2010) Functional redundancy of R7 RGS proteins in ON-bipolar cell dendrites. Investigative Ophthalmology & Visual Science. 51: 686-93 |
| Lee JK, McCoy MK, Harms AS, et al. (2008) Regulator of G-protein signaling 10 promotes dopaminergic neuron survival via regulation of the microglial inflammatory response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8517-28 |
| Jedema HP, Gold SJ, Gonzalez-Burgos G, et al. (2008) Chronic cold exposure increases RGS7 expression and decreases alpha(2)-autoreceptor-mediated inhibition of noradrenergic locus coeruleus neurons. The European Journal of Neuroscience. 27: 2433-43 |
| Blundell J, Hoang CV, Potts B, et al. (2008) Motor coordination deficits in mice lacking RGS9. Brain Research. 1190: 78-85 |
| Lee JK, McCoy MK, Harms AS, et al. (2008) Regulator of G-protein signaling (RGS10) regulates microglial response to chronic inflammatory stimuli and impacts dopaminergic neuron survival. The Faseb Journal. 22 |
| Gold SJ, Hoang CV, Potts BW, et al. (2007) RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14338-48 |
| Psifogeorgou K, Papakosta P, Russo SJ, et al. (2007) RGS9-2 is a negative modulator of mu-opioid receptor function. Journal of Neurochemistry. 103: 617-25 |
| Bezard E, Gold S, Hoang C, et al. (2007) 2.502 RGS9−2 negatively modulates L-dopa-induced dyskinesia in experimental Parkinson's disease Parkinsonism & Related Disorders. 13: S143 |